Enlicitide (Lipfendra): the first oral PCSK9 inhibitor - from macrocyclic peptide innovation to clinical translation - Divyashanthi Chellathambi Malathi; Kumaravel Janakiraman; Sathiya Vinotha Ariyur Thangavelu; Dhivya Ravichandran (International Journal of Basic & Clinical Pharmacology, 2026)